TE
TechEcho
Home24h TopNewestBestAskShowJobs
GitHubTwitter
Home

TechEcho

A tech news platform built with Next.js, providing global tech news and discussions.

GitHubTwitter

Home

HomeNewestBestAskShowJobs

Resources

HackerNews APIOriginal HackerNewsNext.js

© 2025 TechEcho. All rights reserved.

Cancer relapse reduced 44% in early study using mRNA vaccine

50 pointsby wbhardingover 2 years ago

3 comments

Waterluvianover 2 years ago
I came here wondering, &quot;what? a &quot;vaccine&quot; for cancer?&quot; and read the article. Am I right to interpret it as: &quot;we gather cancer cells from a specific patient, assemble a unique identifier for those cells we don&#x27;t want, and then teach the immune system to identify and attack those cells&quot;?<p>I guess that indeed that is a vaccine. I always interpreted &quot;vaccine&quot; as &quot;teaching your body how to kill foreign organisms by training it on what the organisms &quot;look&quot; like.&quot; (yes, this abstraction is certain to be way oversimplified)
评论 #33974341 未加载
t0mas88over 2 years ago
<a href="https:&#x2F;&#x2F;archive.vn&#x2F;OqfLA" rel="nofollow">https:&#x2F;&#x2F;archive.vn&#x2F;OqfLA</a>
2devnullover 2 years ago
Great to keep in mind that this has not been peer reviewed but I’d rather be optimistic than pessimistic about this. Wouldn’t it be nice if the pandemic in some roundabout way speeds us towards better cancer treatments.